3,605
Views
74
CrossRef citations to date
0
Altmetric
Original Articles

Efficacy and safety of radiofrequency, microwave and laser ablation for treating papillary thyroid microcarcinoma: a systematic review and meta-analysis

, , , , &
Pages 1277-1285 | Received 19 Sep 2019, Accepted 24 Nov 2019, Published online: 11 Dec 2019

References

  • Zafon C, et al. Differences in the form of presentation between papillary microcarcinomas and papillary carcinomas of larger size. J Thyroid Res. 2011;2011:639156.
  • Schneider DF, Chen H. New developments in the diagnosis and treatment of thyroid cancer. CA Cancer J Clin. 2013;63:374–394.
  • Mazeh H, Chen H. Advances in surgical therapy for thyroid cancer. Nat Rev Endocrinol. 2011;7:581–588.
  • Sugitani I, Toda K, Yamada K, et al. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg. 2010;34:1222–1231.
  • Sugitani I, Fujimoto Y, Yamada K. Association between serum thyrotropin concentration and growth of asymptomatic papillary thyroid microcarcinoma. World J Surg. 2014;38:673–678.
  • Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24:27–34.
  • Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules–2016 Update. Endocr Pract. 2016;22:1–639.
  • Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1–133.
  • Pacini F, Schlumberger M, Dralle H, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154:787–803.
  • Gharib H. Changing trends in thyroid practice: understanding nodular thyroid disease. Endocr Pract. 2004;10:31–39.
  • Lang BH, Lo CY. Total thyroidectomy for multinodular goiter in the elderly. Am J Surg. 2005;190:418–423.
  • Linos D, Economopoulos KP, Kiriakopoulos A, et al. Scar perceptions after thyroid and parathyroid surgery: comparison of minimal and conventional approaches. Surgery. 2013;153:400–407.
  • Rafferty MA, Goldstein DP, Rotstein L, et al. Completion thyroidectomy versus total thyroidectomy: is there a difference in complication rates? An analysis of 350 patients. J Am Coll Surg. 2007;205:602–607.
  • Kim JH, Baek JH, Lim HK, et al. 2017 thyroid radiofrequency ablation guideline: Korean Society of Thyroid Radiology. Korean J Radiol. 2018;19:632–655.
  • Tian H, Ma N, Xu D, et al. Analysis of therapeutic effect of ultrasound-guided radiofrequency ablation for thyroid microcarcinoma. Chin J Med Imaging Technol. 2018;34:514–517.
  • Luo Y, Zhang M. Ultrasound-guided radiofrequency ablation of low-risk papillary thyroid microcarcinoma: a prospective study. Ultrasound Med Biol. 2017;43:S240–S241.
  • Lim HK, Baek SM, Baek JH. US-guided radiofrequency ablation for primary thyroid cancer: efficacy and safety of long-termfollow-up in a large population. Neuroradiology. 2018;60:271.
  • Jung ED, Shon HS, Jeon EJ. Radiofrequency ablation for the papillary thyroid cancer in high surgical risk patient. Endocrine Rev. 2014;35:S3.
  • Zhang Y, Zhang MB, Luo YK, et al. Effect of chronic lymphocytic thyroiditis on the efficacy and safety of ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma. Cancer Med. 2019;8:5450.
  • Zhang M, Luo Y, Zhang Y, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study. Thyroid. 2016;26:1581–1587.
  • Sun J, Liu X, Zhang Q, et al. Papillary thyroid carcinoma treated with radiofrequency ablation in a patient with hypertrophic cardiomyopathy: a case report. Korean J Radiol. 2016;17:558–561.
  • Kim J-h, Baek JH, Sung JY, et al. Radiofrequency ablation of low-risk small papillary thyroidcarcinoma: preliminary results for patients ineligible for surgery. Int J Hyperthermia. 2017;33:212–219.
  • Jeong SY, Baek JH, Choi YJ, et al. Radiofrequency ablation of primary thyroid carcinoma: efficacy according to the types of thyroid carcinoma. Int J Hyperthermia. 2018;34:611–616.
  • Li J, Liu Y, Liu J, et al. Ultrasound-guided percutaneous microwave ablation versus surgery for papillary thyroid microcarcinoma. Int J Hyperthermia. 2018;34:653–659.
  • Li J, Liu Y, Liu J, et al. A comparative study of short-term efficacy and safety for thyroid micropapillary carcinoma patients after microwave ablation or surgery. Int J Hyperthermia. 2019;36:640–646.
  • Teng D, Sui G, Liu C, et al. Long-term efficacy of ultrasound-guided low power microwave ablation for the treatment of primary papillary thyroid microcarcinoma: a 3-year follow-up study. J Cancer Res Clin Oncol. 2018;144:771–779.
  • Teng DK, Li HQ, Sui GQ, et al. Preliminary report of microwave ablation for the primary papillary thyroid microcarcinoma: a large-cohort of 185 patients feasibility study. Endocrine. 2019;64:109–117.
  • Yue W, Wang S, Yu S, et al. Ultrasound-guided percutaneous microwave ablation of solitary T1N0M0 papillary thyroid microcarcinoma: initial experience. Int J Hyperthermia. 2014;30:150–157.
  • Ji L, Wu Q, Gu J, et al. Ultrasound-guided percutaneous laser ablation for papillary thyroid microcarcinoma: a retrospective analysis of 37 patients. Cancer Imaging. 2019;19:16.
  • Papini E, Guglielmi R, Gharib H, et al. Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk. Thyroid. 2011;21:917–920.
  • Zhang L, Zhou W, Zhan W, et al. Percutaneous laser ablation of unifocal papillary thyroid microcarcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in assessing local therapeutic response. World J Surg. 2018;42:2476–2484.
  • Zhou W, Jiang S, Zhan W, et al. Ultrasound-guided percutaneous laser ablation of unifocal T1N0M0 papillary thyroid microcarcinoma: preliminary results. Eur Radiol. 2017;27:2934–2940.
  • Jeong SY, Baek JH, Choi YJ, et al. Ethanol and thermal ablation for malignant thyroid tumours. Int J Hyperthermia. 2017;33:938–945.
  • Lewis CA, et al. Quality improvement guidelines for central venous access. The Standards of Practice Committee of the Society of Cardiovascular & Interventional Radiology. J Vasc Interv Radiol. 1997;8:475–479.
  • Burke DR, Lewis CA, Cardella JF, et al. Quality improvement guidelines for percutaneous transhepatic cholangiography and biliary drainage. J Vasc Interv Radiol. 2003;14:S243–S246.
  • Whiting PF. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–536.
  • Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. Bmj. 2003;327:557–560.
  • Kim KW, Lee J, Choi SH, et al. Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers-part I. General guidance and tips. Korean J Radiol. 2015;16:1175–1187.
  • Lee J, Kim KW, Choi SH, et al. Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers-part II. Statistical methods of meta-analysis. Korean J Radiol. 2015;16:1188–1196.
  • Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634.
  • Berkey CS, Hoaglin DC, Mosteller F, et al. A random-effects regression model for meta-analysis. Statist Med. 1995;14:395–411.
  • Lee CU, Kim SJ, Sung JY, et al. Needle track tumor seeding after radiofrequency ablation of a thyroid tumor. Jpn J Radiol. 2014;32:661–663.
  • Kim HY, et al. Primary papillary thyroid carcinoma previously treated incompletely with radiofrequency ablation. J Can Res Ther. 2010;6:310–312.
  • Valcavi R, Piana S, Bortolan GS, et al. Ultrasound-guided percutaneous laser ablation of papillary thyroid microcarcinoma: a feasibility study on three cases with pathological and immunohistochemical evaluation. Thyroid. 2013;23:1578–1582.
  • Cui T, Jin C, Jiao D, et al. Safety and efficacy of microwave ablation for benign thyroid nodules and papillary thyroid microcarcinomas: A systematic review and meta-analysis. European Journal of Radiology. 2019;118:58–64.
  • Luo Y, Zhang M. Ultrasound-guided radiofrequency ablation of low-risk papillary thyroid microcarcinoma: A prospective study on 421 patients. Thyroid. 2017;27:A105.
  • Lim HK, Baek SM, Baek JH. US-guided radiofrequency ablation for primary thyroid cancer: Efficacy and safety of long-term follow-up in a large population. CardioVascular and Interventional Radiology. 2017;40:S187.
  • Yekuo L, Shasha W, Feng H. Multipolar radiofrequency ablation in controlling hemorrhage from blunt liver trauma. Am J Emerg Med. 2009;27:197–201.
  • Kontos M, Felekouras E, Drakos E, et al. Radiofrequency tissue ablation in an experimental model of grade IV renal trauma: a preliminary report. Surg Endosc. 2005;19:249–253.
  • Zhou L, Kuang M, Xu Z, et al. Contrast-enhanced sonographically guided thermal ablation for treatment of solid-organ hemorrhage: preliminary clinical results. J Ultrasound Med. 2015;34:907–915.
  • Dobrinja C, Pastoricchio M, Troian M, et al. Partial thyroidectomy for papillary thyroid microcarcinoma: Is completion total thyroidectomy indicated?. Int J Surg. 2017;41:S34–S39.